GeoVax Labs - Company Overview
Featured Videos
Download/View
Recent News
- GeoVax Labs Reports 2012 First Quarter Financial Results
- GeoVax Labs Reports 2011 Financial Results
- GeoVax Announces Private Placement of $2.2 Million
- GeoVax Receives "Allowed to Proceed" Notice for Testing Adjuvanted HIV Vaccine
- GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
- HIV Vaccine Trials: Necessary Next Step
- GeoVax Labs' CEO Update Letter to Shareholders
- GeoVax Labs, Inc. Announces Private Offering of Common Stock and Warrants
- GeoVax Labs' First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
- Clinical Drug Trials — A Growth Industry In GA.
- For World AIDS’ Day, Chuck Panozzo Shows Us The Way
- Styx Debuts New Line of Jewelry, Campaigns for AIDS Awareness
- GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
- Participation Rates in HIV Vaccine Trials Possibly Affected by Misconceptions
- GeoVax Phase 2a Clinical Trial Completes Enrollment
Contacts & RSS
Investor Relations
Erika Moran
Public Relations
Janet Vasquez
Phone
212.825.3210
Subscribe to GeoVax Labs, Inc. news, video, and more.
